Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaike Chemical Group Regulatory News (HAIK)

  • There is currently no data for HAIK

Exit Facility and Cancellation

19 Mar 2018 14:38

RNS Number : 1759I
HaiKe Chemical Group Ltd.
19 March 2018
 

19 March 2018

HaiKe Chemical Group Limited

("HaiKe", the "Group" or the "Company")

Exit Facility, Cancellation and Matched Bargain Facility

Exit Facility

HaiKe Chemical Group Limited, the AIM quoted (AIM: HAIK) specialty chemical business based in Shandong Province, China announces that valid acceptances have been received under the Exit Facility by Hai Yuan Trading in respect of 15,993,036 Ordinary Shares, representing 41.7 per cent. of the Company's total issued Ordinary Shares and 93.3 per cent. of the maximum 17,134,529 Ordinary Shares to which the Exit Facility applied.

The Exit Facility is now closed, and payments to accepting holders of Ordinary Shares or Depositary Interests (as applicable) are expected to be made on 22 March 2018.

Cancellation

The Company expects that the last day of dealings in the Ordinary Shares on AIM will be today, 19 March 2018, and that admission of the Ordinary Shares to trading on AIM will be cancelled at 7.00 a.m. on 20 March 2018.

The Company will also be cancelling the Depositary Interest facility following Cancellation and Depositary Interest holders will receive a share certificate for their cancelled Depositary Interest holding.

Matched Bargain Facility

Following Cancellation, the Company will become a private overseas company and the Company recognises that this will make it more difficult for Shareholders to buy and sell Ordinary Shares should they wish to do so. Therefore, as set out in Part 7 of the circular dated 16 February 2018, the Company is making arrangements for a Matched Bargain Facility to assist Shareholders to trade in the Ordinary Shares following Cancellation. The Matched Bargain Facility will be administered directly by the Company.

Under the Matched Bargain Facility, Shareholders or persons wishing to acquire or dispose of Ordinary Shares in the Company following Cancellation should contact the Company via email to dongyi@haikegroup.com, giving an indication that they are prepared to buy or sell at a specified price. In the event that the Company is able to match that indication with an opposite sell or buy instruction, the Company will contact both parties to arrange the trade.

However, in carrying out such activities, the Company will take no responsibility to match up Shareholders wishing to sell and purchase Ordinary Shares, and no responsibility in respect of the time frame in which introductions or communications (if any) are made or as to the price at which any trades might take place.

Details of the Matched Bargain Facility will also be published on the Company website at www.haikechemical.com.

 

For further information:

 

HaiKe Chemical Group +86 546 7787789

Jes Cui, Chief Financial Officer cuizhiqiang@haikegroup.com 

Yolanda Zhang, Company Secretary yolanda.zhang@haikegroup.com 

 

Stockdale Securities +44 (0) 20 7601 6100

Richard Johnson / Elhanan Lee

 

Cardew Group +44 (0) 20 7930 0777

Shan Shan Willenbrock / Joe McGregor haike@tbcardew.com 

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

Defined terms used in this announcement have the same meaning as in the Company's circular to Shareholders dated 16 February 2018.

 

If any of the above times and/or dates in this announcement change, the revised times and/or dates will be notified to Shareholders by announcement through the Regulatory Information Service.

 

All times stated in this announcement are London times unless otherwise stated.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCJLMITMBJBBRP
Date   Source Headline
19th Mar 20182:38 pmRNSExit Facility and Cancellation
12th Mar 20188:07 amRNSResult of EGM
16th Feb 20187:00 amRNSProposed Cancellation, EGM and Exit Facility
16th Jan 201810:00 amRNSTrading Update
21st Sep 20173:16 pmRNSHolding(s) in Company
1st Sep 20177:00 amRNSHalf-year Report
26th Jun 20177:00 amRNSResult of AGM and Company Update
2nd Jun 20175:11 pmRNSAnnual Financial Report
1st Jun 20177:12 amRNSFinal Results
26th May 201710:43 amRNSBoard Appointment
23rd Jan 20178:00 amRNSTrading Statement
27th Sep 20167:36 amRNSHalf-year Report
6th Sep 20167:09 amRNSTrading Update - Correction
20th Jul 20167:00 amRNSDirectorate Change
27th Jun 201611:38 amRNSResult of AGM
3rd Jun 201611:59 amRNSAnnual Financial Report
31st May 20167:00 amRNSFinal Results
11th May 20169:01 amRNSNotice of Results and Update
8th Jan 201610:38 amRNSTrading Statement
6th Jan 20167:00 amRNSChange of name of Nominated Adviser and Broker
25th Sep 20157:00 amRNSHalf Yearly Report
14th Sep 20157:00 amRNSTrading Statement
8th Jun 20157:00 amRNSResult of AGM
14th May 201512:38 pmRNSAnnual Financial Report and Notice of AGM
1st May 20157:00 amRNSFinal Results
23rd Jan 20157:00 amRNSTrading Statement
30th Sep 20148:02 amRNSHalf Yearly Report
21st Jul 20147:00 amRNSResult of AGM
30th Jun 201410:15 amRNSPosting of Annual Report and Accounts
25th Jun 20147:00 amRNSFinal Results
15th May 20148:23 amRNSResult of General Meeting
29th Apr 201411:59 amRNSProposed Restructuring of the Group
13th Dec 20138:55 amRNSTrading Statement
20th Sep 20137:00 amRNSHalf Yearly Report
22nd Jul 20137:00 amRNSTrading Statement
8th Jul 201310:02 amRNSResult of AGM
12th Jun 20139:04 amRNSNotice of AGM and Posting of Annual Report
20th May 20137:00 amRNSFinal Results
29th Apr 20139:30 amRNSDirectorate Change
15th Feb 201310:56 amRNSDirectorate Change
25th Jan 20137:00 amRNSTrading Update
21st Jan 201310:18 amRNSDirectorate Change
1st Oct 20127:00 amRNSDirectorate Change
7th Sep 201210:51 amRNSHalf Yearly Report
31st Jul 20128:36 amRNSTrading Statement
17th Jul 20127:13 amRNSDividend Payment
17th Jul 20127:10 amRNSBuyout of key refinery subsidiary
19th Jun 20127:00 amRNSResult of AGM and Trading Update
29th May 20122:18 pmRNSDirector/PDMR Shareholding
28th May 201212:01 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.